| Literature DB >> 28087666 |
Jason A Vander Heiden1, Panos Stathopoulos2, Julian Q Zhou1, Luan Chen1, Tamara J Gilbert3, Christopher R Bolen4, Richard J Barohn5, Mazen M Dimachkie5, Emma Ciafaloni6, Teresa J Broering3, Francois Vigneault3, Richard J Nowak2, Steven H Kleinstein7,8,9, Kevin C O'Connor10.
Abstract
Myasthenia gravis (MG) is a prototypical B cell-mediated autoimmune disease affecting 20-50 people per 100,000. The majority of patients fall into two clinically distinguishable types based on whether they produce autoantibodies targeting the acetylcholine receptor (AChR-MG) or muscle specific kinase (MuSK-MG). The autoantibodies are pathogenic, but whether their generation is associated with broader defects in the B cell repertoire is unknown. To address this question, we performed deep sequencing of the BCR repertoire of AChR-MG, MuSK-MG, and healthy subjects to generate ∼518,000 unique VH and VL sequences from sorted naive and memory B cell populations. AChR-MG and MuSK-MG subjects displayed distinct gene segment usage biases in both VH and VL sequences within the naive and memory compartments. The memory compartment of AChR-MG was further characterized by reduced positive selection of somatic mutations in the VH CDR and altered VH CDR3 physicochemical properties. The VL repertoire of MuSK-MG was specifically characterized by reduced V-J segment distance in recombined sequences, suggesting diminished VL receptor editing during B cell development. Our results identify large-scale abnormalities in both the naive and memory B cell repertoires. Particular abnormalities were unique to either AChR-MG or MuSK-MG, indicating that the repertoires reflect the distinct properties of the subtypes. These repertoire abnormalities are consistent with previously observed defects in B cell tolerance checkpoints in MG, thereby offering additional insight regarding the impact of tolerance defects on peripheral autoimmune repertoires. These collective findings point toward a deformed B cell repertoire as a fundamental component of MG.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28087666 PMCID: PMC5296243 DOI: 10.4049/jimmunol.1601415
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422